Shenzhen Capstone Industrial Co.,Ltd.
000038.SZ
Shenzhen Stock Exchange0.52
CNY
-0.03
- -
Shenzhen Capstone Industrial Co.,Ltd.
000038.SZ
(Shenzhen Stock Exchange)
Recent
price
0.52
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Shenzhen Capstone Industrial Co., Ltd. (000038.SZ), founded on June 24, 1987 and headquartered at 3906, Block A, Tianxia Jinniu Plaza, No. 8 Taoyuan Road, Dawangshan Community, Nantou Street, Nanshan District, Shenzhen City, China, operates as a diversified public company listed on the main board of the Shenzhen Stock Exchange since August 8, 1994; it focuses on bioengineering and derivative functional health consumer goods, supply chain services and private capital management, and internet marketing platforms through resource integration and capital operations. The company primarily engages in bioengineering, developing and launching functional cosmetics and everyday chemical products; back-end derivative applications from industrial hemp including textiles, hemp oil, hemp-related foods, drinks, and condiments via its DATONG Hemp Research Institute in Yunnan Province where it holds permits for growing and processing industrial hemp; supply chain services with financial support; private capital management; mobile digital integrated marketing; and online/offline new media advertising. It targets health-conscious consumers, e-commerce platforms, and industrial clients primarily in China, with plans for overseas expansion in plant extracts targeting markets like the United States. Recent developments include a 2016 transformation to internet media business through share issuance and cash payments; entry into bioengineering in 2019 via acquisition of Yunnan Chengbang Fuji Biotechnology Co., Ltd. to focus on the industrial hemp industry chain; 2020 push into R&D and sales of derivative functional consumer goods amid China's second consumption upgrade; completion of the acquisition of Beijing Ranshi Technology Co., Ltd. for CNY 1.1 billion in January 2016 to bolster media capabilities; and plans announced in 2015 to establish a buy-out fund of up to CNY 710 million with partners; the company faced delisting risk warnings, applied for revocation in 2024, and dealt with ongoing regulatory inquiries and goodwill impairment disputes related to prior acquisitions as of 2025.